Dr. Mehran Taban, MD

Dr. Taban practices at Macula Retina Vitreous Center in Los Angeles, California.

Dr. Taban's NPI, 1497943914, was assigned on October 10, 2007. Dr. Taban graduated from University of California, Irvine, California College of Medicine in 2003. Dr. Taban holds California license A108546.

Dr. Taban's primary practice is Macula Retina Vitreous Center, at 1414 S Grand Ave, Los Angeles, CA 90015 in Los Angeles County. The practice phone is (424) 247-9090.

Dr. Taban's primary practice is Macula Retina Vitreous Center in Los Angeles, California. The medical group on file is Harbor-UCLA Medical Center. Dmand AI also links Dr. Taban to 1 more ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Taban practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Taban's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Taban is licensed in California.

CMS data shows 36,824 Medicare services from Dr. Taban across 35 procedure codes in 2024, for 1,387 Medicare patients. Medicare paid $2,884,385 for them.

CMS counts 1,387 Medicare patients who saw Dr. Taban in 2024. The largest group is 65 to 74, with 646 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 42% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Taban's median patient age at 62, with 58% women.

In 2024, Dr. Taban wrote 3,549 Medicare Part D claims for 806 patients. 66% of them were for generic drugs. CMS names the drug for 3,463 of them, across 22 drugs with 11 or more claims each, at $155,612 in total drug cost. In 2023, CMS named 4,646 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Taban for performance year 2024, reported as part of a group. Dr. Taban accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 48 procedures of cataract surgery by Dr. Taban, more than 62% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Taban in 2016. 2016 was the busiest year, with 2. The most frequent topics are Glucocorticoids, Intraocular Pressure and Visual Acuity. Dr. Taban has published most often in Retina. Dr. Taban's most frequent co-authors are Ron P. Gallemore, MD, Behnam Sharareh, MD and Josh O. Wallsh, MD.

Dmand AI links Dr. Taban to 1 clinical trial. Conditions studied include Macular Edema and Macular Degeneration.

CMS Open Payments shows 193 general payments to Dr. Taban from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 60% of the total. Genentech, Inc. paid the most, $2,942. It also lists 1 research payment totaling $9,904 in 2025.

Dr. Taban graduated from University of California, Irvine, California College of Medicine in 2003.